A new mutli-million pharmaceutical manufacturing facility has been opened at Porton Biopharma (PBL).
The minister was accompanied by Sailsbury MP John Glen on 1 February, along with Richard Walters, Alistair Cunningham, and Baroness Jane Scott from Wiltshire Council.
The new facility will increase the capacity of the existing centre used for the production of essential life-saving cancer drug Erwinase®, which saves thousands of children every year.
George Freeman commented "This impressive new facility on the Porton Campus has the potential to make a significant contribution to the local economy and to the UK life sciences sector, which has seen £6bn of investment and created 17,000 jobs since 2011. Not only will it help to drive innovation and growth in the future, it will also produce life-enhancing treatments for the benefit of NHS patients."
Managing director of PBL Dr Roger Hinton responded "I am delighted that the minister and our local MP John Glen have been so supportive in helping PBL to seek to grow the business, which is essential in enabling us to produce greater quantities of life-saving products and to support jobs in the local community."
John Glen MP commented that "PBL will play an essential future role in the regional economy and to help generate prosperity within Salisbury, along with other local initiatives such as the Porton Science Park."